Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
about
Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoproteinThe Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIEAn Epstein-Barr virus protein interacts with NotchSCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigenExpression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic miceThe 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesThe Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaBTruncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiationEBNA2 and activated Notch induce expression of BATFEpstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.Epstein-barr virus sequence variation-biology and diseaseStructural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHEpstein-Barr virus latent genesProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alphaOncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcriptionRBP-L, a transcription factor related to RBP-JkappaEpstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J miceInteraction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.Mutational analysis of the J recombination signal sequence binding protein (RBP-J)/Epstein-Barr virus nuclear antigen 2 (EBNA2) and RBP-J/Notch interaction.The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structureHyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, ZtaAn Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationA viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirusNotch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersActivated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells.EBNA-LP associates with cellular proteins including DNA-PK and HA95.An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3AEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
P2860
Q24311421-4A7559EF-7DC4-4BCC-A9D7-C45A86008FD4Q24329182-4CF1A415-44C9-438F-91A4-08AAB3119CB5Q24529019-00C43453-F2CF-4FB8-AB60-A78B5FE7E8D5Q24556627-E6BD23E7-4ADC-43F6-952A-265B89C6C8E3Q24562912-43D415B1-29DA-4F99-841E-DFF846C92172Q24564767-498721E1-11A8-43CD-B767-944E48DE2DCEQ24646670-1237109E-0826-4BD6-80FF-FBB72E1766FEQ24646694-0428FDD0-6495-4F5D-B892-F31E6075409CQ24650743-7CC33627-CD22-4D9C-A5B2-12E5F5ADA787Q24678677-00309318-AAA3-4FDF-8D9B-688B3905E9D1Q24679432-18522D2A-C20B-4290-80FC-3C25D3ACFF33Q24816875-8E325105-0CD6-46D3-B034-8895A1149F6EQ27003183-1F625E58-4CE7-4EAD-A8D8-6579787A2EFBQ27682610-1B9B13AB-63EA-4EEB-AA2D-3C6F352C2D11Q28082701-325E552D-DE83-4554-B27C-626BEC7478E7Q28114910-DBED3F9E-7BEB-4EA5-A782-26530BD01A52Q28117643-A83EF674-3738-42B3-8964-BD2E71087AB1Q28235557-2E5E03B5-014D-4DCA-AEA4-73489758796FQ28508784-3DFE5566-0421-49A0-91FD-01F30382C666Q28594944-DAA8AC2D-DE35-4192-89AE-8C050993F467Q30939262-58EAE86E-6DAE-4B9A-A060-81C1B7395FB5Q31006410-6D6D876D-A222-4243-A03C-7E32A94A89A5Q31104353-3AF4B7C9-C933-4E42-A591-73ABADD85F7BQ33643991-E5613274-233C-48CD-A674-F7598CF004ACQ33754919-68C7E587-CDCB-4E63-A610-22BBB16DCF37Q33786088-CABF0298-97CD-4EA5-A3C5-6DA02D820A54Q33787090-6FA5AB76-0BC0-4CB5-AD8B-7BABBAF58D6AQ33792860-0506E762-E8B7-4ECC-BAE8-8D99D90735FAQ33797179-D1C0F8D0-7CC0-4DDD-8DA3-C340A80C5B73Q33797347-ABA8A1D3-01CF-41A8-9224-C75AFFF6F15AQ33810690-33AC7328-7EA5-4D39-AACE-02C09A797BC1Q33822549-C6EABADA-43B5-45F9-8F29-02349AE65749Q33825713-60ADB54F-1460-4193-A815-8A6E906A4963Q33838266-39DE76A4-F205-4203-B5E1-121CE1C7FAC0Q33842309-33D1DA79-7B97-4B5D-A3EE-A75FD8888131Q33845947-66FC3F44-3D0B-4A04-A2EC-E34DA5B3A9E4Q33850400-9E735B15-1CCF-4BED-9DE5-BEA5C16753B0Q33850943-7C6869B0-370E-45D0-8833-0AC1D170D158Q33854424-7E7A3229-3119-4580-B8E5-FD183D43F3D9Q33860748-27E2C2A3-91BE-476C-8B8A-D6A58E7DB1CE
P2860
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@ast
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@en
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@nl
type
label
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@ast
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@en
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@nl
prefLabel
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@ast
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@en
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@nl
P2093
P2860
P356
P1476
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.23.9558
P407
P577
1989-12-01T00:00:00Z